Additional definitive proxy soliciting materials and Rule 14(a)(12)[...]
REGENXBIO Announces Lancet Publication of Phase I/IIa Study Evaluating[...]
04/08/2021 | Press release | Distributed by Public on 04/08/2021 14:21
Please select the service you want to use:
Smartlinks | Pulmonx Corporation | News | Health | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Shareholders | Internal Dealings | Medical Supplies and Equipment Companies | Börse Berlin | Börse Düsseldorf | Börse München | Börse Stuttgart | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Nasdaq Global Select Market | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | FINRA Alternative Display Facility (ADF) | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact